@lifescivc.bsky.social
Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
@scottgottliebmd.bsky.social
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Public boards: Pfizer, Illumina, TempusAI.
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@afbiotech.bsky.social
@biotechmiller.bsky.social
20+ years in the biotech business. Analyst, portfolio manager, VC, & now doing communications and strategy at Curevo Vaccine. Avid sailor who races. All views are my own. What are you doing with your one wild and precious life? (Mary Oliver)
@hellmichgroup.bsky.social
Biochemistry/Structural Bio at Uni Jena and Cluster of Excellence 'Balance of the Microverse' (Membrane) protein dynamics admirer, parasite aficionado and coffee addict. Action against #NTDs! www.hellmich-group.de
@ivanoamelio.bsky.social
Dad of 3x 👧, Scientist & Editor Our lab studies the transcriptional and epigenetic responses to stressors in cancer, focusing on their role in driving genomic instability and tumor progression. https://www.biologie.uni-konstanz.de/amelio
@craigmcrews.bsky.social
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
@lisamjarvis.bsky.social
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
@applehelix.bsky.social
Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by Vinay Prasad. http://linkedin.com/in/jliang1/
@helenbranswell.bsky.social
I cover infectious diseases for STAT (www.statnews.com). 2020 Polk winner. Nieman '11. She/her. I write about H5N1 (in all species), Covid, polio, flu, Ebola, RSV, mpox, STIs. Find me on Signal: HBranswell.01
@laurahelmuth.bsky.social
Freelance writer, editor & consultant. Formerly at Scientific American, Washington Post, National Geographic, Slate, Smithsonian & Science. Past president of National Association of Science Writers. Birder.
@edyong209.bsky.social
Writer, journalist. Science, health. Pandemics, animals. Birder, photographer. Many words, some awards. AN IMMENSE WORLD, I CONTAIN MULTITUDES. Married to Liz Neeley, parent to Typo. he/him 📷 Canon R6mkii + RF 800mm Edyong.me
@investrclouseau.bsky.social
Not a CFA, biotech investor, still recovering from a decade in neuroscience, so now focusing on drugs that work
@sarahkarlin-smith.bsky.social
Journalist covering intersection of pharma, health policy & politics for the Pink Sheet. On Signal at SarahKarlinSmith.34 KFF Health News’ ‘What The Health?’ panelist. Co-created Prescription PULSE at Politico. GWU alum, dabbled in SMPA adjunct-ness.
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
@maverickny.bsky.social
Scientist, cancer geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & football
@benoitbruneau.bsky.social
Cardiac developmental biologist. Oakland and San Francisco. Hi friends! 🇨🇦
@biotech.bsky.social
Biotech Investor | Finance / Biochemistry | Avid Runner | Bay Area / Asia
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@maxgelman.bsky.social
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum.
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@rickberke.bsky.social
Co-founder & Executive Editor, STAT (www.statnews.com) @statnews.bsky.social Longtime reporter/editor NYT
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. [email protected] and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@jonathanrockoff.bsky.social
Editor at @wsj.com. Board member of the Association of Health Care Journalists.
@dbsable.bsky.social
Doctor/teacher/writer. Ob/gyn and IVF doc. Roadie for Priya Mayadas. Adjunct @Columbia https://dbsable.substack.com
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@refiningvalue.bsky.social
Health economist writing about HEOR/market access, drug development, biopharma Http://refiningvalue.substack.com
@richardwilson.bsky.social
From the UK to the SF Bay | AAV Biotech, cycling, empty nesting
@davehava.bsky.social
Former Chief Scientific Officer at Synlogic, Metera Pharmaceuticals and Pulmatrix. Microbiologist, immunologist and drug developer. Opinions are my own.
@michaelwong.bsky.social
Biotech venture creation and pharma partnerships at Flagship Pioneering. Company builder by practice, placental biologist by training. 🇨🇦
@ricklivesey.bsky.social
Cellular and molecular neuroscience, neurodegeneration & drug discovery. Founder and CEO of Talisman Therapeutics & Gen2 Neuroscience, honorary prof at UCL. Cambridge UK.
@maxbayer.bsky.social
Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | [email protected] or chat me for Signal. he/him
@randiego.bsky.social
Board member & advocate @SDEEorg. #Entrepreneur, #Biotech, #F1 Nut, #OneManDadBand #endurancerunner. Posts are my own
@noomanhaque.bsky.social
Investor in life sciences & tech. Innovation policy. Fellow at Cambridge University (LCC). Married to a better economist. Cooking. Sports, but badly. ICI was the perfect company once
@robertcoffin.bsky.social
Ex-academic (many years ago) & biotech entrepreneur, including at Biovex & $REPL inc
@pinksheetsutter.bsky.social
Senior Editor, Citeline's Pink Sheet, covering US FDA drug and biologic regulation and approvals. Views are my own.
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: [email protected]